]>
IRCT2016021626599N1 IRCT 2016-03-31 Vice Chancellor for Research, Tehran University of Medical Sciences Sclerotherapy of liver hemangioma Percutanous sclerotherapy of symptomatic liver hemangioma with Bleomycin, a pilot study 2016-03-20 anticipated 5 Complete https://irct.ir/trial/21994 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. 1 Liver symptomatic hemangioma. Intervention group: Under local anesthectic and ultrasound guidance, needle is advanced into the liver hemangioma.Under flurouscopy contrast agent (Lipiodol) is injected to rule out communication of the lesion with portal vein or bile ducts. Then sclerotherapy agent (bleomycin 0.5IU/kg) is injected into the hemangioma tissue. The patient is kept under superviosion for 4 hours in the ward and then is discharged.
public Hadi Rokni Yazdi
Tehran-Bagherkhan Street, Imam Khomeini Hospital, Medical Imaging Center
Tehran Iran (Islamic Republic of) +98 21 6658 1536 rokniyaz@tums.ac.ir Tehran university of Medical Sciences scientific Hadi Rokni yazdi
Tehran-Bagherkhan Street, Imam Khomeini Hospital, Medical Imaging Center
Tehran Iran (Islamic Republic of) +98 21 6658 1536 rokniyaz@tums.ac.ir Tehran University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: Patients with symptomatic liver hemangioma with therapeutic indication with confirmed diagnosis based on triphasic CT-scan or dynamic MRI. Exclusion criteria: Those patients that their abdominal complaints could be attributed to another cause, apart from liver hemangioma 16 years 80 years Both D18.0 Haemangioma, any site Treatment - Other Intervention group: Under local anesthectic and ultrasound guidance, needle is advanced into the liver hemangioma.Under flurouscopy contrast agent (Lipiodol) is injected to rule out communication of the lesion with portal vein or bile ducts. Then sclerotherapy agent (bleomycin 0.5IU/kg) is injected into the hemangioma tissue. The patient is kept under superviosion for 4 hours in the ward and then is discharged Volume of lesion. Timepoint: 6 month after therapy. Method of measurement: Digital volumetry. Abdominal pain. Timepoint: one month and 6 month after procedure. Method of measurement: visual analog scale. Vice Chancellor for Research, Tehran University of Medical Sciences Approved 2015-09-22 Ethics committee of Tehran University of Medical Sciences Keshavarz Blvd Ghods Street Central Building of TUMS 6th Floor Tehran Iran (Islamic Republic of)